Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
Clinical trial NCT00243100 · COMPLETED
Trial details
- NCT number
- NCT00243100
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2011-08-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.